These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. Russell G, Gore CJ, Ashenden MJ, Parisotto R, Hahn AG. Eur J Appl Physiol; 2002 Mar; 86(5):442-9. PubMed ID: 11882931 [Abstract] [Full Text] [Related]
43. Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin. Strauss RG. Transfus Med Rev; 2006 Jan; 20(1):34-44. PubMed ID: 16373186 [Abstract] [Full Text] [Related]
50. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants. Haiden N, Schwindt J, Cardona F, Berger A, Klebermass K, Wald M, Kohlhauser-Vollmuth C, Jilma B, Pollak A. Pediatrics; 2006 Nov; 118(5):2004-13. PubMed ID: 17079573 [Abstract] [Full Text] [Related]
53. Effect of short-term erythropoietin therapy in anemic premature infants. Reiter PD, Rosenberg AA, Valuck R, Novak K. J Perinatol; 2005 Feb; 25(2):125-9. PubMed ID: 15526012 [Abstract] [Full Text] [Related]
54. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. Cotes PM, Pippard MJ, Reid CD, Winearls CG, Oliver DO, Royston JP. Q J Med; 1989 Feb; 70(262):113-37. PubMed ID: 2594953 [Abstract] [Full Text] [Related]